✦ LIBER ✦

Paclitaxel, cisplatin and epirubicin (PCE) combination chemotherapy for newly diagnosed patients with advanced epithelial ovarian cancer (AEOC)

✍ Scribed by C. Papadimitriou; A. Anagnostopoulos; Z. Voulgaris; G. Vlahos; E. Kioses; T. Akrivos; M. Dimopoulos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, epirubicin and paclitaxel com

✍ C. Papadimitriou; D. Lazaris; A. Rodolakis; C. Kiamouris; G.M. Gourgoulis; E. Ga 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Preliminary results of neoadjuvant chemo

✍ Sun-Joo Lee; Byoung-Gie Kim; Jeong-Won Lee; Chang-Soo Park; Je-Ho Lee; Duk-Soo B 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

First-line chemotherapy with epidoxorubi

✍ A Romanini; L Tanganelli; F Carnino; A Fanucchi; R Lionetto; S Pastorino; S Cosi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A phase I study of paclitaxel, topotecan

✍ Deborah K. Armstrong; Michael A. Bookman; William McGuire; Robert E. Bristow; Je 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Effect of Combination Chemotherapy with

✍ David A. Fishman; Richard R. Viscarello; Ilana Cass; Peter E. Schwartz 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 252 KB